1380752-53-3

tert-butyl 3-(3-fluorophenyl)-3-hydroxyazetidine-1-carboxylate

5-Oxaspiro[3.5]non-7-ene, 1,1,2,2,3,3-hexafluoro-

4-Isoquinolinecarbonitrile, 2,3,5,6,7,8-hexahydro-1,6-dimethyl-3-oxo-

Benzenemethanamine,N-(2,2-dimethyl-1-phenylpropylidene)-a-isocyanato-a-(trifluoromethyl)-

Butanoic acid,4-[2-bromo-4-(2,3-dimethylnaphtho[2,3-b]thien-4-yl)-6-ethylphenoxy]-

L-Valine,L-prolyl-L-methionyl-L-a-glutamyl-L-alanyl-L-leucyl-L-alanyl-L-a-glutamyl-L-glutaminyl-

2-(Dimethylamino)-6-(trifluoromethyl)nicotinonitrile

5-Oxazolemethanol,4-[[4-[(5-methyl-2-phenyl-4-oxazolyl)methoxy]phenoxy]methyl]-2-phenyl-

4-Isobenzofurancarbonitrile, 1,3-dihydro-5,7-dimethyl-1-oxo-

6-Benzoxazolamine, 2-[3-[2-(4-morpholinyl)ethoxy]-2-naphthalenyl]-,dihydrochloride

Imidazo[5,1-a]isoquinoline-1-carboxylic acid,5,6-dihydro-8,9-dimethoxy-3-methyl-, methyl ester

31-Oxa-2,8,13,19,24,30-hexaazanonatriacontanoic acid,30-acetyl-9,12,20,23,32-pentaoxo-8,19-bis[(1-oxooctyl)oxy]-, ethyl ester

5-Oxazolamine,4-(3,4-dihydro-6,7-dimethoxy-1-isoquinolinyl)-2-methyl-N-(phenylmethyl)-

4-Isoxazolamine, 5-[2-(1,3-benzodioxol-5-yl)ethenyl]-3-methyl-

1H-1,2,4-Triazole,1-[[3-(4-chlorophenyl)-2-[4-(phenylsulfonyl)phenyl]oxiranyl]methyl]-,trans-

5-Oxazolamine,4-(3,4-dihydro-6,7-dimethoxy-1-isoquinolinyl)-2-methyl-N-phenyl-

4-Isoxazolecarbonitrile, 5-phenyl-3-(phenylamino)-

5-Oxazolamine,4-(3,4-dihydro-6,7-dimethoxy-1-isoquinolinyl)-2-methyl-N-(2-methylpropyl)-, hydrochloride

6-Benzoxazolamine,N,N-diethyl-2-[6-[2-(4-morpholinyl)ethoxy]-2-naphthalenyl]-,dihydrochloride

2,4,6(1H,3H,5H)-Pyrimidinetrione,5-[(4-chlorophenyl)methylene]-1-[(2-hydroxyethoxy)methyl]-

5-Oxazolidinecarbothioic acid, 2-oxo-4-phenyl-, S-(4-methylphenyl)ester, (4R,5R)-rel-

4-Morpholinecarboximidothioic acid, N-phenyl-, 4-chlorophenyl ester

5-Oxazolecarboxamide,2-methyl-N-[4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)-

7H-Pyrimido[4,5-c]carbazole-1,3-diamine, 8,9,10,11-tetrahydro-

Methanone, (2-methyl-1H-indol-3-yl)[4-(methylthio)phenyl]-

4-Imidazolidinone,5-[(1,5-dimethyl-2,3-diphenyl-1H-indol-6-yl)methylene]-2-thioxo-

4-Morpholinecarboxamide,N-(1-pyrrolidinylcarbonyl)-N-[3-(trifluoromethyl)phenyl]-

5-Oxazolamine, N-(1,1-dimethylethyl)-4-(4-nitrophenyl)-2-phenyl-

5-Oxazolamine,4-(3,4-dihydro-6,7-dimethoxy-1-isoquinolinyl)-2-methyl-N-phenyl-,hydrochloride

4-Morpholinecarboxamide,N-[4-[3-methoxy-4-[[[(phenylacetyl)amino]thioxomethyl]amino]phenoxy]-2-pyridinyl]-

4-Isothiazolecarboxylic acid, 5-[(2,3-dimethylphenyl)amino]-3-methyl-,1,1-dimethylethyl ester

Benzoic acid, 4-(decyloxy)-, compd. with4-[(E)-[(4-butylphenyl)imino]methyl]phenol (1:1)

1H-Pyrrole-2-carboxylic acid, 4,4'-thiobis[3,5-dichloro-, dimethyl ester

4-Isoxazolecarbonitrile, 2,3-dihydro-2-methyl-3-phenyl-

5-Oxazolamine, 2-(3-methylphenyl)-4-phenyl-

Pyrido[2,3-b]pyrazin-3(4H)-one,4-[3-(2-amino-4-thiazolyl)phenyl]-2-(phenylmethyl)-

Phenol, 2-[(9-bromononyl)oxy]-

1380752-53-3 msds

CAS No 1380752-53-3 supplier

CASNo 1380752-53-3 distributor

CAS # 1380752-53-3 manufacturer

CAS Number 1380752-53-3 safety

CAS RN 1380752-53-3 wholesale

2026-10-13 Find tert-butyl 3-(3-fluorophenyl)-3-hydroxyazetidine-1-carboxylate,CAS No.1380752-53-3,Formula:C14H18FNO3 in ChemGloble